The global and public health implications of expressing IFNλ4 are significant, as increasing numbers of studies negatively link IFNλ4 expression to disease presentation and severity ranging from Hepatitis C to COVID-196,11–14. This evidence concerns the gene IFNL4 and hepatitis C virus infection.